Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Fidelity Nat
AddedMar 19, 2024
UpdatedJul 16, 2026
Fidelity Nat

Fidelity Nat

Operating

Global FinTech leader in financial services based in Jacksonville, FL.

Location
Jacksonville, FL, US
Founded
1968
Firm
Compare
Portfolio
Fundraising
Employees

Investments

Vast Data
Vast Data

Total Raised

$381M

Rounds

7

Series E$118MDecember 2023
CoreWeave
CoreWeave

Total Raised

$3.5B

Rounds

8

Late Stage Private$642MDecember 2023
Shine Medical Technologies
Shine Medical Technologies
Series D

Total Raised

$742.2M

Rounds

17

Series D$70MOctober 2023
Evozyne
Evozyne

Total Raised

$144.4M

Rounds

3

Series B$81MSeptember 2023
Databricks
Databricks

Total Raised

$29.2B

Rounds

14

Series I$684.6MSeptember 2023
Genesis Therapeutics
Genesis Therapeutics

Total Raised

$256.1M

Rounds

5

Series B$200MAugust 2023
Moloco
Moloco

Total Raised

$191.6M

Rounds

7

Secondary MarketJune 2023
Boundless Bio
Boundless Bio

Total Raised

$251.4M

Rounds

3

Series C$100MMay 2023
Fanatics
Fanatics
Public

Total Raised

$4.9B

Rounds

11

Private Equity$700MDecember 2022
Private Equity$1.5BMarch 2022
Astera Labs
Astera Labs

Total Raised

$206.3M

Rounds

4

Series D$150MNovember 2022
Emalex Biosciences
Emalex Biosciences

Total Raised

$300M

Rounds

3

Series D$250MNovember 2022
Kanmon
Kanmon

Total Raised

$9.2M

Rounds

2

Seed$5MNovember 2022
Local Bounti
Local Bounti
Public

Total Raised

$493.3M

Rounds

5

Post Ipo Equity$23.3MOctober 2022
Wasabi Technologies
Wasabi Technologies

Total Raised

$549.1M

Rounds

14

Series D$125MSeptember 2022
Galvanize Therapeutics
Galvanize Therapeutics

Total Raised

$148.5M

Rounds

4

Series B$100MSeptember 2022
Kasisto
Kasisto

Total Raised

$81.5M

Rounds

8

Series C$15.5MAugust 2022
Cleerly
Cleerly

Total Raised

$280.5M

Rounds

3

Series C$223MJuly 2022
Prime Trust
Prime Trust

Total Raised

$176M

Rounds

9

Series B$107MJune 2022
Talos
Talos

Total Raised

$145M

Rounds

3

Series B$105MMay 2022
Twitter
Twitter
Acquired

Total Raised

$12.9B

Rounds

16

Post Ipo Equity$7.2BMay 2022
Castle Creek Biosciences
Castle Creek Biosciences

Total Raised

$309.4M

Rounds

6

Series Unknown$112.8MMay 2022
Beta Technologies
Beta Technologies

Total Raised

$1.1B

Rounds

4

Series B$375MApril 2022
Circle
Circle
Seed

Total Raised

$1.1B

Rounds

13

Private Equity$400MApril 2022
PrognomiQ
PrognomiQ

Total Raised

$101M

Rounds

2

Series Unknown$46MMarch 2022